Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ioanna Vlachaki"'
Autor:
Ioanna Vlachaki, Matteo Vacchelli, Daniela Zinzi, Edel Falla, Yilin Jiang, Theo Mantopoulos, Dilip Nathwani
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-12 (2021)
Abstract Background Delafloxacin is a novel fluoroquinolone with broad antibacterial activity against pathogens causing acute bacterial skin and skin structure infections (ABSSSI). This network meta-analysis (NMA) was conducted to evaluate the relati
Externí odkaz:
https://doaj.org/article/7d1687cf27834b4abc10838eedd69626
Autor:
Francesco Saverio Mennini, Mario Gori, Ioanna Vlachaki, Francesca Fiorentino, Paola La Malfa, Duccio Urbinati, Massimo Andreoni
Publikováno v:
Health Economics Review, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Background Vaborem is a fixed dose combination of vaborbactam and meropenem with potent activity against target Carbapenem-resistant Enterobacterales (CRE) pathogens, optimally developed for Klebsiella pneumoniae carbapenemase (KPC). The stu
Externí odkaz:
https://doaj.org/article/ed4aefe519a741cda6df5856608b9ac0
Autor:
Edel Falla, Matteo Vacchelli, Ioanna Vlachaki, Dilip Nathwani, Daniela Zinzi, Theo Mantopoulos, Yilin Jiang
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-12 (2021)
BMC Infectious Diseases
BMC Infectious Diseases
Background Delafloxacin is a novel fluoroquinolone with broad antibacterial activity against pathogens causing acute bacterial skin and skin structure infections (ABSSSI). This network meta-analysis (NMA) was conducted to evaluate the relative effica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::233a7fff1b5be6c3c08bde5b5c4cbac1
https://doaj.org/article/7d1687cf27834b4abc10838eedd69626
https://doaj.org/article/7d1687cf27834b4abc10838eedd69626
Autor:
Andrew Dodgson, Daniela Zinzi, Holly Guy, Jasimran Jandu, Theo Mantopoulos, Edel Falla, Ioanna Vlachaki
Publikováno v:
The European Journal of Health Economics
Objective The study objective of this analysis was to determine the cost-effectiveness of vaborem (meropenem-vaborbactam) compared to the best available therapy (BAT) in adult patients with carbapenem-resistant Enterobacteriaceae—Klebsiella pneumon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70e5c60109a37e361c2561e213e6463b
https://doi.org/10.1007/s10198-021-01375-0
https://doi.org/10.1007/s10198-021-01375-0
Publikováno v:
The European journal of health economics : HEPAC : health economics in prevention and care. 23(8)
Background Early discharge (ED) from hospital and outpatient parenteral antibiotic therapy (OPAT) are effective approaches for the management of a range of infections, including acute bacterial skin and skin structure infections (ABSSSI). Strategies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4650b9498741e743bda13cba8338e5a
https://pubmed.ncbi.nlm.nih.gov/35113269
https://pubmed.ncbi.nlm.nih.gov/35113269